MENU
GALT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Galectin Therapeutics (GALT) Earnings Date & Reports

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

GALT is expected to report earnings to rise 26.67% to -18 cents per share on August 18

Galectin Therapeutics GALT Stock Earnings Reports
Q2'25
Est.
$-0.19
Q1'25
Beat
by $0.05
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.04
The last earnings report on May 15 showed earnings per share of -15 cents, beating the estimate of -20 cents. With 150.71K shares outstanding, the current market capitalization sits at 81.65M.
View a ticker or compare two or three
GALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of drugs to combat various diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4960 Peachtree Industrial Boulevard
Phone
+1 678 620-3186
Employees
14
Web
https://www.galectintherapeutics.com